May 12, 2025
DELFI Diagnostics CTO Recognized among 2025 Most Influential Women in Bay Area Business
Apr 25, 2025
DELFI Diagnostics to Present Early Detection and Advanced Cancer Monitoring Technology Updates at AACR Annual Meeting
Jan 08, 2025
DELFI Diagnostics to Participate in J.P. Morgan Healthcare Conference
Dec 02, 2024
DELFI Diagnostics Names Dr. Amoolya Singh as Chief Technology Officer
Oct 29, 2024
DELFI Diagnostics Names Robert Guigley as Chief Commercial Officer to Expand Access to Early Cancer Screening
Oct 28, 2024
DELFI Diagnostics Working with Incendia Therapeutics to Employ Advanced Treatment Monitoring Test in a Phase 1 Clinical Trial
Oct 22, 2024
Florida Lung Health Coalition, with Support from DELFI Diagnostics, RadNet, Inc., and The American Lung Association, to Launch a Revolutionary Lung Cancer Screening Program Focused on Early Detection
Oct 21, 2024
DELFI Diagnostics Study on Cancer Treatment Monitoring Using Fragmentomes Featured in Nature Communications
Aug 26, 2024
DELFI Diagnostics Appoints Thomas Russo as Chief Financial Officer
Jun 04, 2024
DELFI Diagnostics Announces Equity Investment from the Merck Global Health Innovation Fund to Accelerate DELFI's Cancer Screening AI Fragmentomics Platform
Jun 03, 2024
Landmark Blood-Based AI Lung Cancer Screening Test Study Results Published in Cancer Discovery
May 13, 2024
OSF HealthCare and DELFI Diagnostics Announce Collaboration to Improve Lung Cancer Screening Rates
Feb 01, 2024
DELFI Diagnostics Announces Availability of New Fragmentome-Based Cancer Treatment Monitoring Assay
Jan 05, 2024
DELFI Diagnostics Appoints Susan Tousi as New Chief Executive Officer